PROTACs show promise for cancer treatment
Pharmaceutical Technology
JANUARY 25, 2023
Development of PROTACs (PROteolysis TArgeting Chimeras) has advanced fairly rapidly as excitement grows over their potential to selectively degrade proteins that are involved in various diseases, including cancer. PROTACs are a type of heterobifunctional degrader that offers multiple advantages over traditional small molecules.
Let's personalize your content